FI922979A0 - 2-piperidin-l-yl)etanolderivat, deras framstaellning och terapeutiska anvaendning. - Google Patents

2-piperidin-l-yl)etanolderivat, deras framstaellning och terapeutiska anvaendning.

Info

Publication number
FI922979A0
FI922979A0 FI922979A FI922979A FI922979A0 FI 922979 A0 FI922979 A0 FI 922979A0 FI 922979 A FI922979 A FI 922979A FI 922979 A FI922979 A FI 922979A FI 922979 A0 FI922979 A0 FI 922979A0
Authority
FI
Finland
Prior art keywords
ethanolderivat
anvaendning
piperidin
therapeutic
deras framstaellning
Prior art date
Application number
FI922979A
Other languages
English (en)
Other versions
FI922979A (fi
Inventor
Jonathan Frost
Patrick Lardenois
Maria-Carmen Renones
Corinne Rousselle
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9107936A external-priority patent/FR2678270B1/fr
Priority claimed from FR9107934A external-priority patent/FR2678265B1/fr
Priority claimed from FR9204507A external-priority patent/FR2689891B3/fr
Application filed by Synthelabo filed Critical Synthelabo
Publication of FI922979A0 publication Critical patent/FI922979A0/fi
Publication of FI922979A publication Critical patent/FI922979A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
FI922979A 1991-06-27 1992-06-26 2-piperidin-1-yl)etanolderivat, deras framstaellning och terapeutiska anvaendning FI922979A (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9107936A FR2678270B1 (fr) 1991-06-27 1991-06-27 Derives de 2-(piperidin-1-yl)ethanol, leur preparation et leur application en therapeutique.
FR9107934A FR2678265B1 (fr) 1991-06-27 1991-06-27 Derives de 4-(2-phenylethyl)piperidine, leur preparation et leur application en therapeutique.
FR9204507A FR2689891B3 (fr) 1992-04-13 1992-04-13 Derives de 2-(piperidin-1-yl)ethanol, leur preparation et leur application en therapeutique.

Publications (2)

Publication Number Publication Date
FI922979A0 true FI922979A0 (fi) 1992-06-26
FI922979A FI922979A (fi) 1992-12-28

Family

ID=27252473

Family Applications (1)

Application Number Title Priority Date Filing Date
FI922979A FI922979A (fi) 1991-06-27 1992-06-26 2-piperidin-1-yl)etanolderivat, deras framstaellning och terapeutiska anvaendning

Country Status (14)

Country Link
EP (1) EP0524846A1 (fi)
JP (1) JPH05186460A (fi)
KR (1) KR930000505A (fi)
CN (1) CN1069491A (fi)
AU (1) AU644296B2 (fi)
CA (1) CA2072520A1 (fi)
CZ (1) CZ199992A3 (fi)
FI (1) FI922979A (fi)
HU (1) HUT61743A (fi)
IE (1) IE922090A1 (fi)
IL (1) IL102334A0 (fi)
MX (1) MX9203452A (fi)
NO (1) NO922521L (fi)
NZ (1) NZ243337A (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4566093A (en) * 1992-07-08 1994-01-31 Shell Internationale Research Maatschappij B.V. Piperidine derivatives
WO1994010166A1 (en) * 1992-10-30 1994-05-11 Pfizer Inc. Neuroprotective 3,4-dihydro-2(1h)-quinolone compounds
FR2727864B1 (fr) * 1994-12-12 1997-04-04 Synthelabo Utilisation des ligands des sites de liaison peripherique pour les benzodiazepines pour la preparation de medicaments utiles dans le traitement des neuropathies peripheriques
ZA9610745B (en) * 1995-12-22 1997-06-24 Warner Lambert Co 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists
ZA9610741B (en) 1995-12-22 1997-06-24 Warner Lambert Co 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
ZA9610738B (en) 1995-12-22 1997-06-24 Warner Lambert Co Subtype selective nmda receptor ligands and the use thereof
ZA9610736B (en) * 1995-12-22 1997-06-27 Warner Lambert Co 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists
WO1999058117A1 (fr) * 1998-05-13 1999-11-18 Sanofi-Synthelabo Utilisation de composes reduisant l'apoptose
FR2778564B1 (fr) * 1998-05-13 2001-07-13 Sanofi Sa Utilisation de composes reduisant l'apoptose
EP1140107B1 (en) 1998-12-18 2006-07-19 Scios Inc. Agonists and antagonists of peripheral-type benzodiazepine receptors
US20070185168A1 (en) * 2004-04-07 2007-08-09 Takai Haruki S Piperidine derivatives
CN103896835A (zh) * 2014-04-20 2014-07-02 武汉珈瑜科技有限公司 喹啉酮类衍生物及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1030415A (zh) * 1987-02-20 1989-01-18 山之内制药株式会社 饱和的杂环碳酰胺衍生物和它的制备方法
FR2640266B2 (fr) * 1988-07-12 1992-07-10 Synthelabo Derives de (hydroxy-1 piperidinyl-2 alkyl) indolones-2, quinoleinones-2, benzo(b)azepinones-2 et benzimidazolones-2, leur preparation et leur application en therapeutique
JP2969359B2 (ja) * 1989-01-13 1999-11-02 武田薬品工業株式会社 環状アミン化合物
FR2644786B1 (fr) * 1989-03-21 1993-12-31 Adir Cie Nouveaux derives fluoro-4 benzoiques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
JPH03130263A (ja) * 1989-07-19 1991-06-04 Eisai Co Ltd 光学活性ナフチルエタノール誘導体
FR2668149B1 (fr) * 1990-10-18 1994-09-23 Synthelabo Le 1-(3,4-dihydro-2-oxo-1h-quinolein-6-yl)-2-[4-(2-phenyl-ethyl)piperidin-1-yl]ethanol, sa preparation et son application en therapeutique.

Also Published As

Publication number Publication date
HU9202138D0 (en) 1992-10-28
FI922979A (fi) 1992-12-28
MX9203452A (es) 1994-01-31
KR930000505A (ko) 1993-01-15
NO922521L (no) 1992-12-28
AU1858992A (en) 1993-01-07
JPH05186460A (ja) 1993-07-27
EP0524846A1 (fr) 1993-01-27
CZ199992A3 (en) 1993-01-13
IE922090A1 (en) 1992-12-30
NZ243337A (en) 1994-03-25
IL102334A0 (en) 1993-01-14
HUT61743A (en) 1993-03-01
CN1069491A (zh) 1993-03-03
AU644296B2 (en) 1993-12-02
NO922521D0 (no) 1992-06-26
CA2072520A1 (en) 1992-12-28

Similar Documents

Publication Publication Date Title
FI923947A0 (fi) Foerfarande foer pulsbreddsmodulation foer oekad linearitet, minskad kommutationsfoerlust och oekad utspaenning i en vaexelriktare/omriktare.
FI910311A (fi) Kalorifattiga, icke-kariogena aetbara kompositioner och foerfarande foer deras framstaellning.
FI922721A0 (fi) Ammunitionskomponent med laog skade- egenskaper, med en tvaokomponentig explosionsladdning och foerfarande foer uppnaoende av en fragmentationseffekt.
FI922875A0 (fi) Foereningar med reninhaemmande egenskaper, foerfarande foer deras framstaellning och deras anvaendning.
FI922504A0 (fi) Lineaert viskoelastisk och vatten- haltig och vaetskeformig tvaettmedelskomposition, avsedd foer auto- matiska diskmaskiner och havande foerbaettrad fluorstabilitet.
FI922390A0 (fi) Initiatorsuspensioner, deras framstaellning och anvaendning.
FI922491A0 (fi) Foerbaettrad, fosfat och enzymer innehaollande, pulverformig diskmedelskomposition foer automatiska diskmaskiner.
FI922979A0 (fi) 2-piperidin-l-yl)etanolderivat, deras framstaellning och terapeutiska anvaendning.
FI922492A0 (fi) Fosfat och enzymer innehaollande, pulverformig diskmedelskomposition foer automatiska diskmaskiner.
FI922377A0 (fi) Glasblandning, daerav framstaellda glasfibrer och deras framstaellningsfoerfarande.
FI923266A0 (fi) Faestprofil foer ramar foer vaeggelement, doerrar och foenstrar.
FI923204A0 (fi) Nedbrytbara karbonylhaltiga kelateringsmedel, anvaendning av dessa och kompositioner.
FI920400A0 (fi) 2,5-diaryl-1,3,4-oxadiazol-hydroxiester, -hydroxiester,-hydroxisyra och -acetoxiester och deras syntesmetod.
FI921553A0 (fi) Bitumenfri blandning, byggnads- materialblandning och vattenemulsion.
FI924053A0 (fi) Substituerade aminopropaner, foerfarande foer deras framstaellning och deras anvaendning.
FI922876A0 (fi) Heterocykliska foereningar med reninhaemmande egenskaper, foerfarande foer framstaellning av dessa och anvaendning av dessa.
FI914549A0 (fi) Foerfarande och anordning foer kapning av papper, i synnerhet foerperforerat papper.
FI922980A0 (fi) 2-piperidinylpyrimidin-4- karboxamidderivat, framstaellning av dessa och terapeutisk anvaendning av dessa.
FI925639A (fi) Isoxazolylimidazolderivat, foerfarande foer deras framstaellning och deras anvaendning i laekemedel
FI923161A0 (fi) Optiskt aktiva isoindolinderivat, deras framstaellning och anvaendning.
FI904542A (fi) Kopplingsfotsystem foer ytfogningskomponenter, ytfogningskomponent och monteringsfoerfarande foer dessa.
FI902611A0 (fi) Arkivlaoda foer loesa dokument, magasin och prosyrer.
FI911478A0 (fi) Gejdprofil foer balkongglasinsaettningssystem, ledhjul och ramprofil.
FI923251A0 (fi) Substituerade 1-fenyl-1-bensoyl- amino-5-aminopentaner, deras framstaellning och anvaendning.
FI921890A0 (fi) Aminokumarinderivat, deras fram- staellning och anvaendning.